15 Years of Experience With Biphasic Insulin Aspart 30 in Type 2 Diabetes
Drugs in R and D - United Kingdom
doi 10.1007/s40268-018-0228-x
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 21, 2018
Authors
Publisher
Springer Science and Business Media LLC